glimepiride has been researched along with Tauopathies in 1 studies
glimepiride: structure given in first source
Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tauopathy is a group of neurodegenerative diseases in which the pathogenesis processes are related to tau protein." | 1.72 | Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling. ( Azab, SS; El-Desouky, S; Elsherbiny, DA; Salama, M; Zaki, MO, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zaki, MO | 1 |
| El-Desouky, S | 1 |
| Elsherbiny, DA | 1 |
| Salama, M | 1 |
| Azab, SS | 1 |
1 other study available for glimepiride and Tauopathies
| Article | Year |
|---|---|
Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling.
Topics: Animals; Caspase 3; Diabetes Mellitus, Type 2; Disease Models, Animal; Glycogen Synthase Kinase 3 be | 2022 |